Operating Lease, Right-of-Use Asset of Eledon Pharmaceuticals, Inc. from 31 Mar 2019 to 30 Sep 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of lessee's right to use underlying asset under operating lease.
Summary
Eledon Pharmaceuticals, Inc. quarterly Operating Lease, Right-of-Use Asset in USD history and change rate from 31 Mar 2019 to 30 Sep 2025.
  • Eledon Pharmaceuticals, Inc. Operating Lease, Right-of-Use Asset for the quarter ending 30 Sep 2025 was $694,000, a 47% increase year-over-year.
Source SEC data
View on sec.gov
Operating Lease, Right-of-Use Asset, Quarterly (USD)
Operating Lease, Right-of-Use Asset, YoY Quarterly Change (%)

Eledon Pharmaceuticals, Inc. Quarterly Operating Lease, Right-of-Use Asset (USD)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q3 2025 $694,000 +$223,000 +47% 30 Sep 2025 10-Q 14 Nov 2025 2025 Q3
Q2 2025 $773,000 +$152,000 +24% 30 Jun 2025 10-Q 14 Aug 2025 2025 Q2
Q1 2025 $850,000 +$580,000 +215% 31 Mar 2025 10-Q/A 14 Aug 2025 2025 Q1
Q4 2024 $926,000 +$561,000 +154% 31 Dec 2024 10-Q 14 Nov 2025 2025 Q3
Q3 2024 $471,000 +$12,000 +2.6% 30 Sep 2024 10-Q 12 Nov 2024 2024 Q3
Q2 2024 $621,000 +$68,000 +12% 30 Jun 2024 10-Q 19 Aug 2024 2024 Q2
Q1 2024 $270,000 -$377,000 -58% 31 Mar 2024 10-Q/A 19 Aug 2024 2024 Q1
Q4 2023 $365,000 -$374,000 -51% 31 Dec 2023 10-K/A 14 Aug 2025 2024 FY
Q3 2023 $459,000 -$373,000 -45% 30 Sep 2023 10-Q 09 Nov 2023 2023 Q3
Q2 2023 $553,000 -$28,000 -4.8% 30 Jun 2023 10-Q 10 Aug 2023 2023 Q2
Q1 2023 $647,000 -$28,000 -4.1% 31 Mar 2023 10-Q 11 May 2023 2023 Q1
Q4 2022 $739,000 -$29,000 -3.8% 31 Dec 2022 10-K/A 19 Aug 2024 2023 FY
Q3 2022 $832,000 +$610,000 +275% 30 Sep 2022 10-Q 14 Nov 2022 2022 Q3
Q2 2022 $581,000 +$314,000 +118% 30 Jun 2022 10-Q 11 Aug 2022 2022 Q2
Q1 2022 $675,000 +$583,000 +634% 31 Mar 2022 10-Q 12 May 2022 2022 Q1
Q4 2021 $768,000 +$630,000 +457% 31 Dec 2021 10-K 30 Mar 2023 2022 FY
Q3 2021 $222,000 +$39,000 +21% 30 Sep 2021 10-Q 12 Nov 2021 2021 Q3
Q2 2021 $267,000 +$39,000 +17% 30 Jun 2021 10-Q 12 Aug 2021 2021 Q2
Q1 2021 $92,000 -$180,000 -66% 31 Mar 2021 10-Q 14 May 2021 2021 Q1
Q4 2020 $138,000 -$178,000 -56% 31 Dec 2020 10-K 24 Mar 2022 2021 FY
Q3 2020 $183,000 -$177,000 -49% 30 Sep 2020 10-Q 16 Nov 2020 2020 Q3
Q2 2020 $228,000 -$175,000 -43% 30 Jun 2020 10-Q 14 Aug 2020 2020 Q2
Q1 2020 $272,000 -$174,000 -39% 31 Mar 2020 10-Q 15 May 2020 2020 Q1
Q4 2019 $316,000 31 Dec 2019 10-K 31 Mar 2021 2020 FY
Q3 2019 $360,000 30 Sep 2019 10-Q 13 Nov 2019 2019 Q3
Q2 2019 $403,000 30 Jun 2019 10-Q 13 Aug 2019 2019 Q2
Q1 2019 $446,000 31 Mar 2019 10-Q 14 May 2019 2019 Q1
* An asterisk sign (*) next to the value indicates that the value is likely invalid.